Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 21 clinical trials
ZENFlex-Registry to Evaluate the Outcome of Bare Metal Stent-assisted Angioplasty

A prospective, multi-center, single-arm registry to evaluate the safety and efficacy of bare metal stent-assisted percutaneous transluminal angioplasty (PTA) in the treatment of superficial

  • 0 views
  • 06 Sep, 2021
  • 1 location
Carotid Endarterectomy vs. Repeated Carotid Angioplasty and Stenting for In-Stent Restenosis (CERCAS)

Patients with in-stent restenosis in carotid artery indicated to carotid intervention will be randomized into repeated carotid percutaneous transluminal angioplasty with or without stenting or

  • 0 views
  • 07 Jun, 2022
  • 1 location
Far Infrared Therapy on Arteriovenous Fistulas in Hemodialysis Patients

The number of hemodialysis patients in the world are increasing. In order to receive a sufficient dialysis, the patients needs a well functioning and stable vascular access - preferably an arteriovenous fistula (AVF). Unfortunately, the AVF has a high incidence of stenosis with percutaneous trans luminal angioplasty (PTA) as the …

stenosis
dialysis
chronic hemodialysis
  • 0 views
  • 25 Jan, 2021
  • 9 locations
Swedish Drug-elution Trial in Peripheral Arterial Disease

treatments are often indicated to prevent amputations and to alleviate symptoms. More than two thirds of these procedures are presently performed with endovascular techniques (i.e. percutaneous transluminal

coronary artery disease
critical limb ischaemia
ischemia
vascular disease
limb ischemia
  • 40 views
  • 26 Jan, 2021
  • 1 location
Major Adverse Limb Events in Patients With Femoro-popliteal and Below-the-knee Peripheral Arterial Disease Treated With Either Sirolimus-coated Balloon or Standard Uncoated Balloon Angioplasty

The SirPAD trial is an academic, investigator-initiated, single-center, randomized, non-inferiority, open-label clinical trial investigating whether the use of sirolimus-coated balloon catheters in patients with peripheral artery disease of the femoro-popliteal or below-the-knee segment is not inferior to that of uncoated balloon catheters for major clinical outcomes (unplanned major amputation, target …

balloon angioplasty
sirolimus
  • 3 views
  • 13 Apr, 2022
  • 2 locations
Sirolimus Coated Balloon Versus Standard Balloon for SFA and Popliteal Artery Disease (FUTURE-SFA)

This study aims to conduct a randomized, double blind, randomised controlled multicentre trial of sirolimus drug coated balloon versus standard percutaneous transluminal angioplasty for the

transluminal angioplasty
arteriopathy
angiography
stenosis
stenotic
  • 0 views
  • 24 Mar, 2022
  • 3 locations
SirolimUs CoaTed Balloon for The TrEatment of Below The Knee Arterial Disease (FUTURE-BTK)

This study aims to conduct a randomized, double blind, randomised controlled multicentre trial of sirolimus drug coated balloon versus standard percutaneous transluminal angioplasty for the

transluminal angioplasty
arteriopathy
angiography
stenosis
stenotic
  • 0 views
  • 23 Mar, 2022
  • 3 locations
Drug-coated Balloon for Takayasu Arteritis Associated Renal Artery Stenosis

control in spite of two or more anti-hypertension drugs. Percutaneous transluminal angioplasty (PTA) is recommended for hypertension caused by TARAS. In previous clinical practice, we observed

  • 0 views
  • 29 May, 2021
  • 1 location
Sirolimus- vs. Paclitaxel-Drug Coated Ballons in Patients With Peripheral Artery Disease (SIRONA)

This study is a prospective, interventional, multi-center 1:1 randomized non-inferiority trial. The trial evaluates the safety and efficacy of the Magic Touch PTA sirolimus drug-coated balloon in comparison to the treatment with PTX drug-coated balloon (control device) in patients with femoropopliteal artery disease.

  • 0 views
  • 13 Mar, 2022
  • 10 locations
Study of the R3 Vascular Drug-Eluting Bioresorbable Scaffold in Treating Below the Knee Arterial Disease (RESOLV I)

This first-in-human clinical feasibility study will evaluate the safety and performance of the R3 Vascular MAGNITUDE® Bioresorbable Drug-Eluting Scaffold and Delivery System in patients undergoing treatment for peripheral arterial disease severe enough to have significantly reduced the blood supply to their leg. The severe reduction in blood flow causes lifestyle …

ischemia
atherectomy
leg pain
gangrene
angiography
  • 0 views
  • 25 May, 2022
  • 5 locations